Webcast Alert: PURE Bioscience Announces LHA Life Sciences & Med Tech Day 2010 Presentation

NEW YORK, July 14 /PRNewswire-FirstCall/ -- PURE Bioscience (PURE) announces the following Webcast:

If you are unable to participate during the live webcast, the call will be available for replay at http://www.investorcalendar.com/ClientPage.asp?ID=160319 or http://www.investorcalendar.com/.

PURE Bioscience (Nasdaq: PURE) is leveraging its silver dihydrogen citrate-based antimicrobial (SDC) platform technology through proprietary products and partnerships in multiple industries.  Patent-protected SDC has been widely studied by the company and its licensees and is differentiated by superior efficacy, reduced toxicity, formulation compatibility with other compounds, and the inability of bacteria (including MRSA) to form resistance.  SDC has application as a disinfectant, an ingredient in personal care, household and industrial products, and in prescription pharmaceutical products and medical devices. In April 2010 PURE completed the six-year process to gain EPA registration of SDC as a sanitizer for food contact surfaces and equipment. The leading branding and marketing firm Richmont Sciences launched the SDC-based disinfectant IV-7 Ultimate Germ Defense™ in March 2010 to institutional markets, and followed with a direct (multi-level) marketing launch in May.  In June 2010, PURE Biosciences was added to the Russell 2000® Index.   Additional information regarding PURE Bioscience can be found at www.purebio.com

SOURCE PURE Bioscience